www.globenewswire.com/news-release/2022/...porate-Update.html
Pre market
www.nasdaq.com/de/market-activity/stocks/alna/real-time
Pre market
www.nasdaq.com/de/market-activity/stocks/alna/real-time
|
Phase 3 Studie des Hauptkandidaten Reloxalase soll eingestellt werden
"Following a statistical analysis on unblinded data from the URIROX-2 Trial for reloxaliase in enteric hyperoxaluria, the management has decided to terminate the study. However, subject to negotiations with the contract research organization on payments, Allena (ALNA) says it plans to advance two mid-stage trials for ALLN-346 in the treatment of hyperuricemia.
“However, the company has limited financial resources, and there can be no assurance that these trials will be completed, or if completed, that they will be successful,” Allena
seekingalpha.com/news/...on-plans-to-end-trial-for-lead-asset
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 2 | 86 | Allena beachten! | Tiger | Tiger | 08.09.22 15:18 | |
| 110 | Allena Pharma bereit für den Milliardenmarkt! | moneywork4me | Nobsy11 | 04.07.22 18:31 |